Hovione

Overview of Hovione, a pharmaceutical company

Hovione

Ivan Villax, founder of Hovione

Hovione is a multinational pharmaceutical company that specializes in the development and manufacture of active pharmaceutical ingredients (APIs), drug product intermediates, and drug products. The company is known for its expertise in particle engineering, spray drying, and the production of inhalation products.

History

Hovione was founded in 1959 by Ivan Villax, a Hungarian chemist who fled to Portugal during the Hungarian Revolution of 1956. The company started as a small laboratory in Lisbon, Portugal, focusing on the production of corticosteroids. Over the years, Hovione expanded its operations globally, establishing manufacturing sites in the United States, China, and Ireland.

Products and Services

Hovione offers a wide range of products and services, including:

• Active Pharmaceutical Ingredients (APIs): Hovione manufactures a variety of APIs for different therapeutic areas, including anti-infectives, central nervous system agents, and respiratory drugs.
• Particle Engineering: The company provides particle engineering services such as spray drying, crystallization, and micronization to enhance the solubility and bioavailability of drugs.
• Inhalation Products: Hovione is a leader in the development and manufacture of inhalation products, including dry powder inhalers and nebulizers.
• Contract Development and Manufacturing Organization (CDMO) Services: Hovione offers end-to-end solutions for drug development and manufacturing, from early-stage development to commercial production.

Research and Development

Hovione invests significantly in research and development (R&D) to innovate and improve its processes and products. The company collaborates with academic institutions and industry partners to advance pharmaceutical technologies and address unmet medical needs.

Global Presence

Hovione operates manufacturing facilities in several countries, including:

• Portugal: The headquarters and main manufacturing site are located in Loures, near Lisbon.
• United States: A manufacturing site in East Windsor, New Jersey, focuses on spray drying and particle engineering.
• China: The site in Taizhou, Zhejiang Province, supports the production of APIs and intermediates.
• Ireland: The Cork site specializes in the production of inhalation products and APIs.

Related Pages

• Pharmaceutical industry
• Active pharmaceutical ingredient
• Drug development
• Inhalation therapy